参考文献/References:
[1] 杨培增.葡萄膜炎诊治概要[M].北京:人民卫生出版社,2016.
YANG P Z.Essentials of the diagnosis & treatment of uveitis[M].Beijing:People’s Medical Publishing House,2016.
[2] International Team for the Revision of the International Criteria for Behet’s Disease (ITR-ICBD).The International Criteria for Behet’s Disease (ICBD):a collaborative study of 27 countries on the sensitivity and specificity of the new criteria[J].J Eur Acad Dermatol Venereol,2014,28(3):338-347.
[3] YANG P,REN Y,LI B,FANG W,MENG Q,KIJLSTRA A.Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients[J].Ophthalmology,2007,114(3):606-614.
[4] GRITZ D C,WONG I G.Incidence and prevalence of uveitis in Northern California:the Northern California epidemiology of uveitis study[J].Ophthalmology,2004,111(3):491-500.
[5] LIORENC V,MESQUIDA M,SAINZ DE LA MAZA M,KELLER J,MOLINS B,ESPINOSA G,et al.Epidemiology of uveitis in a Western urban multiethnic population.The challenge of globalization[J].Acta Ophthalmol,2015,93(6):561-567.
[6] MISEROCCHI E,FOGLIATO G,MODORATI G,BANDELLO F.Review on the worldwide epidemiology of uveitis[J].Eur J Ophthalmol,2013,23(5):705-717.
[7] CHEN S C,CHUANG C T,CHU M Y,SHEU S J.Patterns and etiologies of uveitis at a tertiary referral center in Taiwan[J].Ocul Immunol Inflamm,2017,25(Supl):S31-S38.
[8] YANG P,ZHANG Z,ZHOU H,LI B,HUANG X,GAO Y,et al.Clinical patterns and characteristics of uveitis in a tertiary center for uveitis in China[J].Curr Eye Res,2005,30(11):943-948.
[9] CHAN C K,WU Z H,LUK F O,LIU D T,FAN A H,LEE V Y,et al.Clinical characteristics of intermediate uveitis in Chinese patients[J].Ocul Immunol Inflamm,2013,21(1):71-76.
[10] NESS T,BOEHRINGER D,HEINZELMANN S.Intermediate uveitis:pattern of etiology,complications,treatment and outcome in a tertiary academic center[J].Orphanet J Rare Dis,2017,12(1):81.
[11] FREEDMAN M S,COMI G,DE STEFANO N,BARKHOF F,POLMAN C H,UITDEHAAG B M,et al.Moving toward earlier treatment of multiple sclerosis:findings from a decade of clinical trials and implications for clinical practice[J].Mult Scler Relat Disord,2014,3(2):147-155.
[12] CHANG J H,WAKEFIELD D.Uveitis:a global perspective[J].Ocul Immunol Inflamm,2002,10(4):263-279.
[13] YANG P,FANG W,MENG Q,REN Y,XING L,KIJLSTRA A.Clinical features of Chinese patients with Behcet’s disease[J].Ophthalmology,2008,115(2):312-318.
[14] WANG L Y,ZHAO D B,GU J,DAI S M.Clinical characteristics of Behcet’s disease in China[J].Rheumatol Int,2010,30(9):1191-1196.
[15] ZHANG Z,HE F,SHI Y.Behcet’s disease seen in China:analysis of 334 cases[J].Rheumatol Int,2013,33(3):645-648.
相似文献/References:
[1]张楠,卢弘.环孢素A在非感染性葡萄膜炎治疗中的应用[J].眼科新进展,2017,37(3):293.[doi:10.13389/j.cnki.rao.2017.0074]
ZHANG Nan,LU Hong.Application of cyclosporine A in noninfectious uveitis[J].Recent Advances in Ophthalmology,2017,37(7):293.[doi:10.13389/j.cnki.rao.2017.0074]
[2]张晓培,姚进.阿达木单抗应用于非感染性葡萄膜炎的治疗研究现状[J].眼科新进展,2021,41(3):286.[doi:10.13389/j.cnki.rao.2021.0060]
ZHANG Xiaopei,YAO Jin.Research status of adalimumab in non-infectious uveitis[J].Recent Advances in Ophthalmology,2021,41(7):286.[doi:10.13389/j.cnki.rao.2021.0060]
[3]程希,孙旭芳.抗肿瘤坏死因子-α及白细胞介素抑制剂治疗非感染性葡萄膜炎的研究进展[J].眼科新进展,2021,41(4):376.[doi:10.13389/j.cnki.rao.2021.0079]
CHENG Xi,SUN Xufang.Progress of anti-tumor necrosis factor-α and interleukin inhibitors in the treatment of non-infectious uveitis[J].Recent Advances in Ophthalmology,2021,41(7):376.[doi:10.13389/j.cnki.rao.2021.0079]